Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
Enhancer of zeste homolog 2 (EZH2) is a histone-lysine N-methyltransferase enzyme that catalyzes the addition of methyl groups to histone H3 at lysine 27, leading to gene silencing. Mutation or over-expression of EZH2 has been linked to many cancers including renal carcinoma. Recent studies have sho...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2021-02-01
|
| Reeks: | Frontiers in Physiology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fphys.2021.640700/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|